Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 14/20 | 0.72 |
| ▸ | ABL1 | P00519 | 7/20 | 0.72 |
| ▸ | LCK | P06239 | 5/20 | 0.72 |
| ▸ | CSF1R | P07333 | 5/20 | 0.72 |
| ▸ | FLT1 | P17948 | 4/20 | 0.72 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.72 |
| ▸ | PRKACA | P17612 | 3/20 | 0.72 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.72 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.72 |
| ▸ | MET | P08581 | 2/20 | 0.72 |
| ▸ | GSK3A | P49840 | 2/20 | 0.72 |
| ▸ | GSK3B | P49841 | 2/20 | 0.72 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.72 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.72 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.72 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.72 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.72 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.72 |
| ▸ | PAK4 | O96013 | 1/20 | 0.72 |
| ▸ | RET | P07949 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3363647 | 0.91 | KDR (0.68) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL27657352 | 0.91 | KDR (0.66) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL4737713 | 0.87 | KDR (0.77) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL27825044 | 0.86 | KDR (0.76) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL4739859 | 0.85 | KDR (0.63) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL27657344 | 0.85 | KDR (0.69) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL27636418 | 0.85 | KDR (0.66) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL27636364 | 0.85 | KDR (0.68) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL27636372 | 0.85 | KDR (0.65) | KDRABL1LCKCSF1RFLT1 | |
| SCHEMBL4740070 | 0.84 | KDR (0.62) | KDRABL1LCKCSF1RFLT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1826324-B | indazole, Benzisoxazole and benzisothiazole kinase inhibitors | ABBOTT LABORATORIES (US) | 2011-12-07 | — | — | CN | claimed |
| EP-1638941-B1 | INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS | ABBOTT LAB (US) | 2010-06-02 | — | — | EP | claimed |
| WO-2008080110-A1 | METHODS FOR TREATING MACULAR EDEMA AND PATHOLOGIC OCULAR ANGIOGENESIS USING A NEUROPROTECTIVE AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR | ALCON, INC. (CH) | 2008-07-03 | — | — | WO | claimed |
| CN-1826324-A | Indazole, benzisoxazole and benzisothiazole kinase inhibitors | ABBOTT LAB (US) | 2006-08-30 | — | — | CN | claimed |
| CN-102417487-A | Indazole, benzisoxazole and benzisothiazole kinase inhibitors | ABBOTT LAB | 2012-04-18 | — | — | CN | disclosed |
| CN-1826324-B | indazole, Benzisoxazole and benzisothiazole kinase inhibitors | ABBOTT LABORATORIES (US) | 2011-12-07 | — | — | CN | disclosed |
| CN-101827584-A | Solid dispersion product of N-aryl ureido drugs | ABBOTT GMBH & CO KG | 2010-09-08 | — | — | CN | disclosed |
| CN-1826324-A | Indazole, benzisoxazole and benzisothiazole kinase inhibitors | ABBOTT LAB (US) | 2006-08-30 | — | — | CN | disclosed |